femMED Breast Health
femMED Breast Health, NPN 80039359: natural health product licensed in Canada. Medicinal ingredients: Schisandra chinensis, Indole-3-carbinol, Hydroxymatairesinol Lignana.
If this product were sold in France
- To check
Indole-3-carbinol is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
POL-NF-00429. Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Schisandra chinensis Source : Berry extract Extraction ratio : 4:1 Dry plant equivalent : 300 mg | 75 mg | Not calculated |
| Indole-3-carbinol | 200 mg | Not calculated |
| Hydroxymatairesinol Lignana Source : Acétate de potassium | 7 mg | Not calculated |
| Hydroxymatairesinol Lignana Source : Picea abies | 7 mg | Not calculated |
Non-medicinal ingredients
Saveur de fraise, Lécithine, Fructo-oligosaccharides, Stéarate de magnésium, Cellulose, microcristalline, Chlorophylle, Eau, Glycérine, Gélatine, Cire d'abeille, Rice maltodextrin
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Helps to promote healthy estrogen metabolism and support a healthy estrogen metabolite ratio.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No warning text available in the imported data.
Product record
- Other names
- Estrogen Balance
- Licence holder
- femMED Canada, Inc.
- NPN or DIN-HM
- 80039359
- Status
- Active licence
- Licence date
- 31 January 2013
- Revision date
- 22 April 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80039359
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “femMED Breast Health (femMED Canada, Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80039359-femmed-breast-health, updated 22 April 2021.